ClinVar Miner

Submissions for variant NM_005188.4(CBL):c.1754G>T (p.Arg585Leu)

dbSNP: rs727504640
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000155901 SCV000205612 uncertain significance not specified 2013-06-28 criteria provided, single submitter clinical testing The Arg585Leu variant in CBL has not been previously reported in individuals wi th clinical features of Noonan syndrome or in large population studies. Computat ional analyses (biochemical amino acid properties, conservation, AlignGVGD, Poly Phen2, and SIFT) do not provide strong support for or against an impact to the p rotein. In summary, additional information is needed to fully assess the clinica l significance of the Arg585Leu variant.
Institute Of Molecular Biology And Genetics, Federal Almazov National Medical Research Centre RCV000492503 SCV000494670 likely pathogenic CBL-related disorder criteria provided, single submitter research
Invitae RCV001244706 SCV001417948 uncertain significance RASopathy 2024-01-29 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 585 of the CBL protein (p.Arg585Leu). This variant is present in population databases (rs727504640, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of hypertrophic cardiomyopathy (PMID: 25731833). ClinVar contains an entry for this variant (Variation ID: 179116). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CBL protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.